Providers and patients with questions about this recall are advised to contact Teva's Medical Information by phone at 888-838-2872, option 3, then option 4, or by email at [email protected] ...

The US FDA has approved the first combination of an angiotensin receptor blocker—valsartan—with a calcium blocker—amlodipine—for the initial treatment of hypertension. The product, known ...